InvestorLens

CLDX — CELLDEX THERAPEUTICS INC NEW

Public company

Sign in to save4 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About CELLDEX THERAPEUTICS INC NEW (CLDX)

CELLDEX THERAPEUTICS INC NEW (CLDX) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Steve Cohen (Point72 Asset Management), valued at $102M. Across recent filings, tracked investors recorded 4 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in CLDX

100
/100
Strong Institutional Accumulation
Added / Increased4
Reduced0
Exited0
BearishBullish
Crowded Trade Score™

How many top investors track CLDX

27
/100
Emerging Interest
4investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

CLDX Ownership Composition

How CELLDEX THERAPEUTICS INC NEW is held across tracked investor types, based on reported 13F positions.

Dominant Type
Hedge Funds
68% of tracked value
Institutions
4
tracked investors
Total Reported
$151M
combined 13F value
Sectors2
  • Hedge Funds67.8%
  • Other32.2%
Hedge Funds(1)
67.8%
Other(3)
32.2%

Tracked investors reporting CLDX

  • Steve CohenMar 31, 2026
    Point72 Asset Management
    Shares
    3.2M
    Value
    $102.5M
    % Portfolio
    0.13%
  • Izzy EnglanderMar 31, 2026
    Millennium Management
    Shares
    1.3M
    Value
    $39.8M
    % Portfolio
    0.02%
  • Ken GriffinMar 31, 2026
    Citadel Advisors
    Shares
    242.9K
    Value
    $7.7M
    % Portfolio
    0.00%
  • Paul Tudor JonesMar 31, 2026
    Tudor Investment Corp
    Shares
    35.4K
    Value
    $1.1M
    % Portfolio
    0.00%

Recent activity

Frequently asked questions

How many institutional investors hold CLDX?
4 tracked institutional investors disclosed a position in CLDX (CELLDEX THERAPEUTICS INC NEW) in their most recent 13F filing.
Who is the largest institutional holder of CLDX?
Steve Cohen, Point72 Asset Management, holds the largest disclosed position in CLDX, valued at $102M.
Did institutional ownership of CLDX increase or decrease?
Across recent 13F filings, tracked investors recorded 4 new positions, 0 increased, 0 reduced, and 0 fully exited CLDX.
Where does this CLDX ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.
CLDX (CELLDEX THERAPEUTICS INC NEW) — Institutional Holders — InvestorLens